How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study

Purpose: To evaluate the predictive value of the disintegrin and metalloproteinases, ADAM-9, ADAM-10, ADAM-11, and ADAM-12, and of the matrix metalloproteinases, MMP-2 and MMP-9, in patients with recurrent breast cancer treated with tamoxifen. Experimental Design: A retrospective study was done on 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2005-10, Vol.11 (20), p.7311-7321
Hauptverfasser: SIEUWERTS, Anieta M, MEIJER-VAN GELDER, Marion E, TIMMERMANS, Mieke, TRAPMAN, Anita M. A. C, RODRIGUEZ GARCIA, Roberto, ARNOLD, Miranda, GOEDHEER, Anneke J. W, PORTENGEN, Henk, KLIJN, Jan G. M, FOEKENS, John A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!